medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2011, Number 2

<< Back Next >>

Rev Invest Clin 2011; 63 (2)

Bone mineral density in patients with type 2 diabetes

Sauque-Reyna L, Salcedo-Parra MA, Sánchez-Vargas PR, Flores-Helguera JD, Badillo-Sánchez C, Reza-Albarrán A, Rodríguez-Morán M, Guerrero-Romero F

Language: Spanish
References: 63
Page: 162-169
PDF size: 72.03 Kb.


ABSTRACT

Objective. To establish whether type 2 diabetes (T2D) is associated with changes in the bone mineral density (BMD) of femoral neck, total hip and lumbar spine. Material and methods. Comparative cross-sectional study that included 450 patients aged 30 years or more; 245 with, and 205 without T2D. Groups were matched by age. Degenerative joint disease, rheumatoid arthritis, neoplasia, renal failure, chronic liver disease, alcohol intake, prior treatment with drugs that modulate the BMD, Diabetes Mellitus Type 1 and other endocrinopathies were exclusion criteria. Results. In the overall group, the presence of menopause was associated with osteoporosis in the hip (odds ratio -OR-4.2; CI95% 1.4-6.1), whereas T2D was a protective factor (OR 0.8; CI95% 0.4-0.9). Among premenopausal women, central obesity and total adiposity were associated with osteoporosis in the hip (OR 1.9; CI95% 1.1-3.9 and OR 2.1; CI95% 1.2-8.7) and femoral areas (OR 2.1; CI95% 1.2-4.1 and OR 2.3; CI95% 1.3-7.1); T2D remained as protective factor (OR 0.7; CI95% 0.5-0.9 and OR 0.6; CI95% 0.4-0.9). The adjusted analysis by BMI, waist circumference, and total adiposity showed that T2D remained as a protective factor for osteoporosis in the hip (OR 0.8; CI95% 0.6-0.9) and femoral areas (OR 0.7; CI95% 0.5-0.9). Conclusions. Our results suggest that T2D is an independent protective factor for osteoporosis.


REFERENCES

  1. Wild S, Roglic G, Green A, Sicree R, King H. Global Prevalence of Diabetes Estimates for the year 2000 and projections for 2030 Diabetes Care 2004; 27: 1047-53.

  2. Olaiz-Fernández G, Rojas R, Aguilar-Salinas CA, Rauda J, Villalpando S. Diabetes mellitus in Mexican adults: results from the 2000 National Health Survey. Salud Publica Mex 2007; 49(Suppl. 3): S331-S337.

  3. Secretaría de Salud. Estadísticas de mortalidad en México: muertes registradas en el año 2000. Salud Pública Mex 2002; 44: 266-82.

  4. Secretaría de Salud. Estadísticas de mortalidad en México: muertes registradas en el año 2001. Salud Pública Mex 2002; 44: 565-81.

  5. Secretaría de Salud. Estadísticas de mortalidad en México: muertes registradas en el año 2002. Salud Pública Mex 2004; 46: 169-85.

  6. Secretaría de Salud. Estadísticas de mortalidad en México: muertes registradas en el año 2003. Salud Pública Mex 2005; 47: 171-87.

  7. EFFO and NOF. Who are candidates for prevention and treatment for osteoporosis? Osteoporos Int 1997; 7: 1.

  8. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006; 17: 1726-33.

  9. NOF (2002). America’s bone health: The state of osteoporosis and low bone mass in our nation. In: America’s Bone Health (Prevalence Report): http://www.nof.org/advocacy/ prevalence

  10. Riera-Espinoza G. Epidemiology of osteoporosis in Latin America 2008. Salud Publica Mex 2009; 51(Suppl. 1): S52-S55.

  11. Clark P, Cons-Molina F, Deleze M, Talavera JO, Palermo L, Cummings SO. The prevalence of radiographic vertebral fractures in Latin American countries: the Latin American Vertebral Osteoporosis Study (LAVOS). Osteoporos Int 2009. [Epub ahead of print].

  12. De Lago Acosta A, Parada Tapia MG, Somera Iturbide J. Osteoporosis prevalence in open population at Mexico City. Ginecol Obstet Mex 2008; 76: 261-6.

  13. Murrillo-Uribe A, Delezé-Hinojosa M, Aguirre E, Villa A, Calva J, Cons F, et al. Osteoporosis en la mujer postmenopáusica mexicana. Magnitud del problema. Estudio multicéntrico. Ginecol Obstet Mex 1999; 67: 227-33.

  14. Gómez-García F, Vázquez-Martínez JL, Lara-Rodríguez ML. Osteoporosis and osteopenia in female health workers from Mexico City. Acta Ortop Mex 2008; 22: 292-302.

  15. Hofbauer LC, Brueck CC, Singh SK, Dobnig H. Osteoporosis in Patients with Diabetes Mellitus. Review J Bone Miner Res 2007; 22: 1317-28.

  16. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes–a metaanalysis. Osteoporos Int 2007; 18: 427-44.

  17. Janghorbani M, Van Dam RM, WillettWC, Hu FB. Systematic review of Type 1 and Type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 2007; 166: 495-505.

  18. Leidig-Bruckner G, Ziegler R. Diabetes mellitus a risk for osteoporosis? Exp Clin Endocrinol Diabetes 2001; 109(Suppl. 2): S493-S514.

  19. Mastrandrea LD, Wactawski-Wende J, Donahue RP, Hovey KM, Clark A, Quattrin T. Young women with type 1 diabetes have lower bone mineral density that persists over time. Diabetes Care 2008; 31: 1729-35.

  20. Hamilton EJ, Rakic V, Davis WA, Chubb SA, Kamber N, Prince RL, Davis TM. Prevalence and predictors of osteopenia and osteoporosis in adults with Type 1 diabetes. Diabet Med 2009; 26: 45-52.

  21. Strotmeyer ES, Cauley JA, Orchard TJ, Steenkiste AR, Dorman JS. Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women. Diabetes Care 2006; 29: 306-11.

  22. Bonds DE, Larson JC, SchwartzAV, Strotmeyer ES, Robbins J, Rodriguez BL, et al. Risk of fracture in women with type 2 diabetes: the Women’s Health Initiative Observational Study. J Clin Endocrinol Metab 2006; 91: 3404-10.

  23. Nicodemus KK, Folsom AR, Iowa Women’s Health Study 2001 Type 1 and type 2 diabetes and incident hip fractures inpostmenopausal women. Diabetes Care 2001; 24: 1192-97.

  24. Vestergaard P, Rejnmark L, Mosekilde L. Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 2005; 48: 1292-9.

  25. Lipscombe LL, Jamal SA, Booth GL, Hawker GA. The risk of hip fractures in older individuals with diabetes: a populationbased study. Diabetes Care 2007; 30: 835-41.

  26. Bonds DE, Larson JC, Schwartz AV, Strotmeyer ES, Robbins J, Rodriguez BL, Johnson KC, et al. Risk of fracture in women with type 2 diabetes: the Women’s Health Initiative Observational Study. J Clin Endocrinol Metab 2006; 91: 3404-10.

  27. Lopez-Ibarra PJ, Pastor MM, Escobar-Jiménez F, Pardo MD, González AG, Luna JD, Requena ME, et al. Bone mineral density at time of clinical diagnosis of adult onset type 1 diabetes mellitus. Endocr Pract 2001; 7: 346–51.

  28. Kemink SA, Hermus AR, Swinkels LM, Lutterman JA, Smals AG. Osteopenia in insulin-dependent diabetes mellitus: Prevalence and aspects of pathophysiology. J Endocrinol Invest 2000; 23: 295-303.

  29. Munoz-Torres M, Jodar E, Escobar-Jimenez F, Lopez-Ibarra PJ, Luna JD. Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulindependent diabetes mellitus. Calcif Tissue Int 1996; 58: 316-19.

  30. Gunczler P, Lanes R, Paoli M, Martinis R, Villaroel O, Weisinger JR. Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2001; 14: 525-8.

  31. Gunczler P, Lanes R, Paz-Martinez V, Martins R, Esaa S, Colmenares V, et al. Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followedlongitudinally. J Pediatr Endocrinol Metab 1998; 11: 413-9.

  32. Al-Maatouq MA, El-Desouki MI, Othman SA, Mattar EH, Babay ZA, Addar M. Prevalence of osteoporosis among postmenopausal females with diabetes mellitus. Saudi Med J 2004; 25: 1423-7.

  33. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995; 332: 767-73.

  34. Nicodemus KK, Folsom AR. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 2001; 24: 1192-7.

  35. Horiuchi T, Nakamura T, Miyao M, Inoue J, Hattori A, Araki A, Shiraki M, et al. Bone mineral density in postmenopausal elderly women with type 2 diabetes. Nippon Ronen Igakkai Zasshi 1995; 32: 756-60.

  36. Sosa M, Dominguez M, Navarro MC, Segarra MC, Hernández D, de Pablos P, Betancor PJ. Bone mineral metabolism is normal in non-insulin-dependent diabetes mellitus. J Diabetes Complications 1996; 10: 201-05.

  37. Al-Elq AH, Sadat-Ali M. Diabetes mellitus and male osteoporosis. Is there a relationship? Saudi Med J 2006; 27: 1729-33.

  38. Christensen JO, Svendsen OL. Bone mineral density in pre-and postmenopausal women with insulin-dependent and non-insulindependent diabetes mellitus. Osteoporos Int 1999; 10: 307-11.

  39. Kao WH, Kammerer CM, Schneider JL, Bauer RL, Mitchell BD. Type 2 diabetes is associated with increased bone mineral density in Mexican-American women. Arch Med Res 2003; 34: 399-406.

  40. Strotmeyer ES, Cauley JA, Schwartz AV, Nevitt MC, Resnick HE, Zmuda JM, et al. Diabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: The Health, Aging, and Body Composition Study. J Bone Miner Res 2004; 19: 1084-91.

  41. van Daele PL, Stolk RP, Burger H, Algra D, Grobbee DE, Hofman A, Birkenhäger JC, et al. Bone Density in Non-Insulin-Dependent Diabetes Mellitus: The Rotterdam Study. Ann Intern Med 1995; 122: 409-14.

  42. Dennison EM, Syddall HE, Aihie Sayer A, Craighead S, Phillips DI, Cooper C. Type 2 diabetes mellitus is associated with increased axial bone density in men and women from the Hertfordshire Cohort Study: evidence for an indirect effect of insulin resistance? Diabetologia 2004; 47: 1963-8.

  43. Barrett-Connor E, Holbrook TL. Sex differences in osteoporosis in older adults with non-insulin dependent diabetes mellitus. JAMA 1992; 268: 3333-37.

  44. Sahin G, Bagis S, Cimen OB, Ozisik S, Guler H, Erdogan C. Lumbar and femoral bone mineral density in type 2 Turkish diabetic patients. Act Médica (Hradec Kralove) 2001; 44: 141-3.

  45. de Liefde I, van der Klift M, de Laet CE, van Daele PL, Hofman A, Pols HA. Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int 2005; 16: 1713-20.

  46. Rakic V, Davis WA, Chubb SAP, Islam FMA, Prince RL, Davis TME. Bone mineral density and its determinants in diabetes: the Fremantle Diabetes Study. Diabetologia 2006; 49: 863-71.

  47. WHO Scientific Group on The Assessment of Osteoporosis at Primary Health Care Level. Summary Meeting Report Brussels, Belgium, 5-7 May 2004. http://www.who.int/chp/topics/ Osteoporosis.pdf

  48. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-07.

  49. Kanis JA, Johansson H, Johnell O, Oden A, De Laet C, Eisman JA, Pols H, et al. Alcohol intake as a risk factor for fracture. Osteoporosis International 2005; 16: 737-42.

  50. WHO, Obesity and overweight: Fact sheet N°311 2006, September 2006: www.who.int/mediacentre/factsheets/ fs311/en/ index.html

  51. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.

  52. Sección 4: Guía para las mediciones físicas (Step 2). Vigilancia STEPS 2. www.who.int/chp/steps/Parte3_Seccion4.pdf

  53. Thrailkill KM, Lumpkin ChK Jr, Bunn RC, Kemp SF, Fowlkes JL. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab 2005; 289: E735-E745.

  54. Haffner SM, Bauer RL. The association of obesity and glucose and insulin concentrations with bone density in premenopausal and postmenopausal women. Metabolism 1993; 42: 735-38.

  55. Barrett-Connor E, Kritz-Silverstein D. Does hyperinsulinemia preserve bone? Diabetes Care 1996; 19: 1388-92.

  56. Thrailkill KM. Insulin-like growth factor-I in diabetes mellitus: its physiology, metabolic effects and potential clinical utility. Diabetes Technol Ther 2000; 2: 69-80.

  57. Yano H, Ohya K, Amagasa T. Effects of insulin on in vitro bone formation in fetal rat parietal bone. Endocr J 1994; 41: 293-300.

  58. Mohan S, Richman C, Guo R, Amaar Y, Donahue LR, Wergedal J, Baylink DJ. Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and - independent mechanisms. Endocrinology 2003; 144: 929-36.

  59. Suzuki K, Miyakoshi N, Tsuchida T, Kasukawa Y, Sato K, Itoi E. Effects of combined treatment of insulin and human parathyroid hormone (1–34) on cancellous bone mass and structure in streptozotocin induced diabetic rats. Bone 2003; 33: 108-14.

  60. Gourlay ML, Brown SA. Clinical considerations in premenopausal osteoporosis. Arch Intern Med 2004; 164: 603-14.

  61. Chau DL, Goldstein-Fuchs J, Edelman SV. Osteoporosis among patients with diabetes: an overlooked disease. Diabetes Spectrum 2003; 16: 176-82.

  62. Nelson HD, Helfand M, Woolf SH, Allen JD. Screening for postmenopausal osteoporosis: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002; 137: 529-41.

  63. Teegarden D, Lyle RM, McCable GP. Dietary calcium, protein, and phosphorus are related to bone mineral density and content in young women. Am J Clin Nutr 1998; 68: 749-54.




2020     |     www.medigraphic.com